ARCADIUM LITHM (ALTM)
(Delayed Data from NYSE)
$3.90 USD
+0.10 (2.63%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $3.90 0.00 (0.00%) 5:58 PM ET
4-Sell of 5 4
C Value D Growth C Momentum D VGM
Arcadium (ALTM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$10.43 | $25.00 | $5.00 | 174.47% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Arcadium comes to $10.43. The forecasts range from a low of $5.00 to a high of $25.00. The average price target represents an increase of 174.47% from the last closing price of $3.80.
Analyst Price Targets (14)
Broker Rating
Arcadium currently has an average brokerage recommendation (ABR) of 2.07 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 2.13 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, eight are Strong Buy, representing 53.33% of all recommendations. A month ago, Strong Buy made up 46.67%, while Buy represented 6.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 7 | 7 | 7 |
Buy | 0 | 0 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.07 | 2.07 | 2.13 | 2.07 | 2.07 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/9/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Strong Buy | Strong Buy |
4/3/2024 | Raymond James | Pavel S Molchanov | Moderate Buy | Strong Buy |
3/6/2024 | Piper Sandler | Charles N Neivert | Strong Sell | Strong Sell |
2/26/2024 | Scotiabank | Ben Isaacson | Hold | Hold |
1/22/2024 | Macquarie Capital Securities | Austin Yun | Not Available | Strong Buy |
1/11/2024 | Vertical Research Partners | Kevin W Mccarthy | Not Available | Hold |
12/28/2023 | Mizuho SecuritiesUSA | John Roberts | Hold | Hold |
11/6/2023 | Loop Capital Markets | Christopher Kapsch | Not Available | Strong Buy |
11/1/2023 | BMO Capital Markets | Joel Jackson | Not Available | Hold |
10/23/2023 | B. Riley Securities | Matthew A Key | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.07 |
ABR (Last week) | 2.07 |
# of Recs in ABR | 15 |
Average Target Price | $10.43 |
LT Growth Rate | 20.00% |
Industry | Chemical - Specialty |
Industry Rank by ABR | 44 of 252 |
Current Quarter EPS Est: | 0.04 |